GO:0070075 tear secretion: Genes, Functions and Methods

Tear secretion (GO:0070075) is the regulated release of the aqueous layer of the tear film from the lacrimal glands. This process is essential for maintaining ocular surface health, as tears clean and lubricate the eyes and provide a protective barrier against environmental insults. The tear film is a highly organized structure whose aqueous component is produced by lacrimal gland acinar cells under tight neural and hormonal control. Understanding the molecular and cellular mechanisms of tear secretion is critical for researchers studying dry eye disease, lacrimal gland dysfunction, and ocular surface inflammation. The process involves multiple secretory pathways, including regulated exocytosis of proteins such as lysozyme and lactoferrin, as well as the secretion of electrolytes and water that establish the tear film's osmotic and ionic environment. Recent work has begun to map the neural circuits that govern tear secretion, revealing specialized brainstem and autonomic pathways that link sensory stimulation to lacrimal gland output. In parallel, studies of tear film lipids and thickness have highlighted the importance of the aqueous layer in maintaining optical clarity and tear stability. Because tear secretion is a quantifiable physiological process, it serves as a tractable model for investigating regulated secretion, exocrine gland biology, and neuro-epithelial interactions. This article synthesizes authoritative GO annotations and published literature to provide a research-grade overview of tear secretion, its genetic and molecular underpinnings, disease relevance, and the experimental methods used to study it.

GO:0070075 tear secretion is defined as the regulated release of the aqueous layer of the tear film from the lacrimal glands. Tears are the liquid product of lacrimation, a process that cleans and lubricates the eyes. The secreted tear fluid is not merely water; it contains a defined set of solutes and proteins including water, mucin, lipids, lysozyme, lactoferrin, lipocalin, lacritin, immunoglobulins, glucose, urea, sodium, and potassium. This definition distinguishes tear secretion from other secretory processes by its anatomical source (lacrimal glands) and its physiological role in ocular surface maintenance.

Tear secretion is important because it maintains the aqueous layer of the tear film, which is required for ocular surface hydration, lubrication, and protection. Disruption of this process leads to dry eye disease, a common condition in which inflammation and impaired secretion create a vicious cycle of ocular surface damage. The neural control of tear secretion involves dedicated circuits that translate sensory stimuli into secretory output, making it a model system for studying neuro-exocrine regulation. Additionally, the protein and lipid composition of tears provides biomarkers for lacrimal gland function and ocular surface health.

The following genes and proteins are involved in tear secretion, based on their roles in lacrimal gland function, tear film composition, and regulatory pathways.

Tear secretion is regulated primarily by neural circuits that integrate sensory input from the ocular surface with autonomic output to the lacrimal glands. Parasympathetic and sympathetic nerves release neurotransmitters such as acetylcholine, vasoactive intestinal peptide, and norepinephrine, which act on lacrimal gland acinar cells to stimulate secretion. Inflammatory mediators can also modulate tear secretion, and emerging targets of inflammation are being investigated in dry eye disease. Additionally, systemic factors such as aerobic exercise have been shown to increase tear secretion in diabetic mice, suggesting metabolic regulation of lacrimal gland function.

Dry eye disease is a multifactorial condition characterized by insufficient tear secretion or excessive tear evaporation, leading to ocular surface inflammation and discomfort. Inflammatory cytokines such as IL-1 beta and TNF are elevated in dry eye and can impair lacrimal gland secretory function. Emerging therapies target inflammatory pathways to restore tear secretion.

Diabetes can impair tear secretion, and studies in type 2 diabetic mice have shown that aerobic exercise increases tear secretion. This suggests that metabolic and lifestyle factors can influence lacrimal gland function.

Dysfunction of lacrimal gland acinar cells can result from altered secretory pathways, as demonstrated by studies on cathepsin S secretion. Understanding these pathways may reveal therapeutic targets for restoring tear production.

Tear secretion can be quantified using the phenol red thread test or Schirmer test in animal models and humans. These methods measure the volume of tears produced over a defined period and are used to assess lacrimal gland function.

Tear fluid can be collected and analyzed by proteomics or ELISA to measure specific proteins such as lysozyme, lactoferrin, and cathepsin S. These analyses provide insights into secretory pathway activity and biomarker discovery.

Optical coherence tomography and interferometry can measure tear film thickness, which reflects the aqueous layer volume and stability. These techniques are used to evaluate tear film dynamics in health and disease.

Neural circuits controlling tear secretion can be mapped using viral tracing and optogenetics in animal models. These approaches identify brain regions and autonomic pathways that regulate lacrimal gland output.

Researchers studying tear secretion-related genes often need to determine whether a candidate gene is causally involved in lacrimal gland function or tear film homeostasis. EDITGENE provides a comprehensive suite of CRISPR-based services to enable such investigations, from gene knockout to precise point mutations and overexpression models.

Tear secretion (GO:0070075) is a vital biological process that maintains ocular surface health through the regulated release of the aqueous tear film from lacrimal glands. Its neural regulation, secretory pathways, and molecular components are active areas of research, with direct relevance to dry eye disease and other ocular surface disorders. Advances in CRISPR-based gene editing and screening technologies offer powerful tools to dissect the genetic basis of tear secretion and identify new therapeutic targets.